FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020429971> ?p ?o ?g. }

• W2020429971 endingPage "80" @default.
• W2020429971 startingPage "73" @default.
• W2020429971 abstract "17-Allylamino-17-demethoxygeldanamycin (17-AAG), a typical Hsp90 inhibitor derived from geldanamycin (GA), has entered Phase III clinical trials for cancer therapy. However, it has several significant limitations such as poor solubility, limited bioavailability and unacceptable hepatotoxicity. In this study, the anticancer activity and mechanism of SNX-25a, a novel Hsp90 inhibitor, was investigated comparing with that of 17-AAG. We showed that SNX-25a triggered growth inhibition more sensitively than 17-AAG against many human cancer cells, including K562, SW-620, A375, Hep-2, MCF-7, HepG2, HeLa, and A549 cell lines, especially at low concentrations (<1 μM). It showed low cytotoxicity in L-02, HDF and MRC5 normal human cells. Compared with 17-AAG, SNX-25a was more potent in arresting the cell cycle at G2 phase, and displayed more potent effects on human cancer cell apoptosis and Hsp90 client proteins. It also exhibited a stronger binding affinity to Hsp90 than 17-AAG using molecular docking. Considering the superiority effects on Hsp90 affinity, cell growth, cell cycle, apoptosis, and Hsp90 client proteins, SNX-25a is supposed as a potential anticancer agent that needs to be explored in detail." @default.
• W2020429971 created "2016-06-24" @default.
• W2020429971 creator A5003931980 @default.
• W2020429971 creator A5010724776 @default.
• W2020429971 creator A5029434966 @default.
• W2020429971 creator A5029941351 @default.
• W2020429971 creator A5035832716 @default.
• W2020429971 creator A5039161740 @default.
• W2020429971 creator A5041593217 @default.
• W2020429971 creator A5044011685 @default.
• W2020429971 creator A5044544424 @default.
• W2020429971 creator A5050892040 @default.
• W2020429971 date "2014-07-01" @default.
• W2020429971 modified "2023-10-14" @default.
• W2020429971 title "SNX-25a, a novel Hsp90 inhibitor, inhibited human cancer growth more potently than 17-AAG" @default.
• W2020429971 cites W1596038553 @default.
• W2020429971 cites W1963823444 @default.
• W2020429971 cites W1964632863 @default.
• W2020429971 cites W1966229978 @default.
• W2020429971 cites W1966492828 @default.
• W2020429971 cites W1968007975 @default.
• W2020429971 cites W1974952480 @default.
• W2020429971 cites W1980282046 @default.
• W2020429971 cites W2000929246 @default.
• W2020429971 cites W2003799931 @default.
• W2020429971 cites W2012118931 @default.
• W2020429971 cites W2018750602 @default.
• W2020429971 cites W2058641375 @default.
• W2020429971 cites W2060902443 @default.
• W2020429971 cites W2064630223 @default.
• W2020429971 cites W2077244922 @default.
• W2020429971 cites W2085961273 @default.
• W2020429971 cites W2088059732 @default.
• W2020429971 cites W2092284969 @default.
• W2020429971 cites W2094605114 @default.
• W2020429971 cites W2096955693 @default.
• W2020429971 cites W2103327164 @default.
• W2020429971 cites W2104357345 @default.
• W2020429971 cites W2115527176 @default.
• W2020429971 cites W2117692326 @default.
• W2020429971 cites W2129004089 @default.
• W2020429971 cites W2145933752 @default.
• W2020429971 cites W2150118709 @default.
• W2020429971 cites W2151697521 @default.
• W2020429971 cites W2157371003 @default.
• W2020429971 cites W2315613727 @default.
• W2020429971 cites W2321109948 @default.
• W2020429971 doi "https://doi.org/10.1016/j.bbrc.2014.05.076" @default.
• W2020429971 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24879994" @default.
• W2020429971 hasPublicationYear "2014" @default.
• W2020429971 type Work @default.
• W2020429971 sameAs 2020429971 @default.
• W2020429971 citedByCount "10" @default.
• W2020429971 countsByYear W20204299712015 @default.
• W2020429971 countsByYear W20204299712016 @default.
• W2020429971 countsByYear W20204299712017 @default.
• W2020429971 countsByYear W20204299712018 @default.
• W2020429971 countsByYear W20204299712020 @default.
• W2020429971 countsByYear W20204299712021 @default.
• W2020429971 countsByYear W20204299712022 @default.
• W2020429971 crossrefType "journal-article" @default.
• W2020429971 hasAuthorship W2020429971A5003931980 @default.
• W2020429971 hasAuthorship W2020429971A5010724776 @default.
• W2020429971 hasAuthorship W2020429971A5029434966 @default.
• W2020429971 hasAuthorship W2020429971A5029941351 @default.
• W2020429971 hasAuthorship W2020429971A5035832716 @default.
• W2020429971 hasAuthorship W2020429971A5039161740 @default.
• W2020429971 hasAuthorship W2020429971A5041593217 @default.
• W2020429971 hasAuthorship W2020429971A5044011685 @default.
• W2020429971 hasAuthorship W2020429971A5044544424 @default.
• W2020429971 hasAuthorship W2020429971A5050892040 @default.
• W2020429971 hasConcept C104317684 @default.
• W2020429971 hasConcept C105696609 @default.
• W2020429971 hasConcept C109316439 @default.
• W2020429971 hasConcept C121608353 @default.
• W2020429971 hasConcept C1491633281 @default.
• W2020429971 hasConcept C185592680 @default.
• W2020429971 hasConcept C190283241 @default.
• W2020429971 hasConcept C202751555 @default.
• W2020429971 hasConcept C205260736 @default.
• W2020429971 hasConcept C2775932338 @default.
• W2020429971 hasConcept C2777366897 @default.
• W2020429971 hasConcept C2777560012 @default.
• W2020429971 hasConcept C2779707156 @default.
• W2020429971 hasConcept C2780297055 @default.
• W2020429971 hasConcept C29537977 @default.
• W2020429971 hasConcept C502942594 @default.
• W2020429971 hasConcept C54355233 @default.
• W2020429971 hasConcept C55493867 @default.
• W2020429971 hasConcept C62112901 @default.
• W2020429971 hasConcept C81885089 @default.
• W2020429971 hasConcept C86803240 @default.
• W2020429971 hasConcept C96232424 @default.
• W2020429971 hasConcept C98274493 @default.
• W2020429971 hasConceptScore W2020429971C104317684 @default.
• W2020429971 hasConceptScore W2020429971C105696609 @default.
• W2020429971 hasConceptScore W2020429971C109316439 @default.
• W2020429971 hasConceptScore W2020429971C121608353 @default.

• next